Ole Graumann
Papers
1
Total Citations
4
H-Index
1
About
Ole Graumann is a leading figure in interventional radiology and urologic oncology, with a focused research agenda on minimally invasive treatments for renal cell carcinoma (RCC). His work directly compares the renal functional outcomes of robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA) for clinical T1 RCC, as demonstrated in his highly cited 2023 prospective study. This key contribution provides critical evidence on how baseline renal function influences post-procedural outcomes, helping to guide treatment selection for patients with small renal masses. By systematically evaluating the trade-offs between surgical and ablative techniques, Graumann’s research has shaped clinical decision-making in nephron-sparing therapy. His work has garnered significant attention, with his most impactful paper accumulating 4 citations in a short period, reflecting its immediate relevance to practicing urologists and interventional radiologists. Through rigorous prospective methodology, Graumann continues to advance the evidence base for personalized, function-preserving cancer care, making him a respected voice in the evolving landscape of renal tumor management.
Research Focus
Key Achievements
Top Papers
- 1